SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-10-013356
Filing Date
2010-02-16
Accepted
2010-02-16 16:59:02
Documents
1
Group Members
JOHN S. CLARK IISOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP, LLCSOUTHPOINT GP, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d71068dsc13gza.htm SC 13G/A 78043
  Complete submission text file 0000950123-10-013356.txt   80146
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50514 | Film No.: 10609169
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017
Business Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

IRS No.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A